BRAF and melanoma: Gopal et al. found that a subset of BRAF or NRAS mutated melanomas and cell lines resistant to BRAF and/or MEK inhibition that displayed activation of the Akt pathway also exhibited an increased an OXPHOS transcriptional signature [301].